dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
[]
 agreed. although now there is no need to rely on pet for decision making which can be hard in resource limited settings.
Clinician-researcher-educator @MSKCancerCenter Tweets about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews @RoswellPark